The Impact of Smoking on Rheumatoid Arthritis Activity
DOI:
https://doi.org/10.12970/2310-9874.2014.02.01.3Keywords:
RA, Smoking, DAS28, RF, CRPAbstract
Introduction: The Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic disease that is usually the most evident and commonly manifested on diarthrosis joints. The initial etiological factors that trigger the immune-inflammatory response still remains unknown. RA is result of the simultaneous influence of genetic risk factors, external factors and changes in immune system.
Objective: The goal of this study was to determine the mutual correlation between smoking and RA activities expressed by the quantitative values of laboratory and disease activity parameters.
Material and Method: The open clinical retrospective study included 100 RA patients stages from I to IV aged from 21 to 77 ys. There were 85 (85%) females and 15 (15%) males selected by randomization. The study analysed: age, gender, smoking, duration of smoking, sedimentation rate (ESR), rheumatoid factor (RF), C-Reactive Protein (CRP) anti-cyclic citrullinated peptide (anti-CCP) antibodies and X-ray. Statistical analyses was done with SPSS software, Student's t-test and chi-square test.
Results: The quantitative values of laboratory parameters are directly related with the smoking period. All inflammatory markers were increased in both groups, but more elevated in smoker's group. The only statistical significance was found in anti-CCP where this test was significantly higher compared to non-smokers. There was no statistical significance in the onset of disease, gender, ESR, CRP, RF, and radiological changes between two groups, although smokers had some more higher values.
Conclusion: Smoking plays significant role in RA activity and leads to longer duration of symptoms and increased disability. All inflammatory markers were increased in both groups, but more elevated in smoker's group, with the only significancy in anti-CCP level. The cessation of smoking should be part of disease management proccess.
References
Stefanovic S. Interna medicina. Medicinska knjiga Beograd 1990; 1406-37.
Kenneth G, Cerhanc J, Kolluric S, Ohashid K, Hunninghakeb G, Schwartzb A. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997; 56: 463-9. http://dx.doi.org/10.1136/ard.56.8.463
Sugiyama D. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2010; 69: 70-81. http://dx.doi.org/10.1136/ard.2008.096487
Elizabeth W, Cook N, Manson J, Buring J, Hennekens C. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999; 42: 910-7. http://dx.doi.org/10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D
Young B, Gleeson M, Cripps A. C-reactive protein: a critical review. Pathology. Discipline of Pathology. University of Newcastle1991; 36: 1036-44.
Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000; 27: 630-7.
Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J. A new model for an etiology of rheumatoid arthritis. Rheumatology Unit. Arthritis Rheum 2006; 54: 38-46. http://dx.doi.org/10.1002/art.21575
Saaga K, Cerhanc J, Kolluric S, Ohashid K, Hunninghakeb G. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997; 56: 463-9. http://dx.doi.org/10.1136/ard.56.8.463
Manfredsdottir F, Vikingsdottir T, Jonsson T. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Med Rheumatol 2007; 45: 734-40. http://dx.doi.org/10.1093/rheumatology/kei240
Másdóttir B, Jónsson T, Manfreðsdóttir V, Víkingsson A, Brekkan A, Valdimarsson H. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatol Oxford 2000; 39: 1202-5. http://dx.doi.org/10.1093/rheumatology/39.11.1202
Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA. C-reactive protein: a family of proteins to regulate cardiovascular function. Am J Kidney Dis 2006; 47: 212-22. http://dx.doi.org/10.1053/j.ajkd.2005.10.028